AnaptysBio Inc:企業のM&A・事業提携・投資動向

◆英語タイトル:AnaptysBio Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
◆商品コード:DATA904C1981
◆発行会社(調査会社):MarketLine
◆発行日:2018年7月
◆ページ数:76
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD700 ⇒換算¥103,600見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD1,050 ⇒換算¥155,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

AnaptysBio Inc – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
Summary

Marketline’s AnaptysBio Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by AnaptysBio Inc since January2007.

Synopsis

Marketline’s Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.

Key Highlights

This report includes AnaptysBio Inc’s contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.

The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by AnaptysBio Inc. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.

Scope

- Provides intelligence on AnaptysBio Inc’s M&A, strategic partnerships and alliances, capital raising and private equity transactions.
- Detailed reports of various financial transactions undertaken by AnaptysBio Inc and its subsidiaries since 2007.
- Information about key financial and legal advisors for AnaptysBio Inc’s financial deals transactions.
- Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.

Reasons to buy

- Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances.
- Form an independent opinion about AnaptysBio Inc’s growth strategies through the organic and inorganic activities undertaken since 2007.
- Track your competitors’ business structure and growth strategies.

【レポートの目次】

Table of Contents
COMPANY OVERVIEW AND KEY FACTS 2
TABLE OF CONTENTS 5
LIST OF TABLES 6
LIST OF FIGURES 6
TARGETS AND PARTNERS 7
PARTNERSHIP 8
Partnership – Overview 8
Partnership – Deal reports 9
CAPITAL RAISING 47
Capital Raising – Overview 47
Capital Raising – Deal reports 48
APPENDIX 66
Contact Us 66
About MarketLine Financial Deals Database 66
Deal Definition and Methodology 68
About MarketLine 75

List of Tables
Table 1: AnaptysBio Inc partnership volume and value trend (2014-YTD2018)
Table 2: AnaptysBio Inc partnership trend by key deal type (2014-YTD2018)
Table 3: AnaptysBio Inc capital raising volume and value trend (2014-YTD2018)
Table 4: AnaptysBio Inc capital raising by deal type (2014-YTD2018)

List of Figures
Figure 1: AnaptysBio Inc partnership volume and value trend (2014-YTD2018)
Figure 2: AnaptysBio Inc partnership trend by key deal type (2014-YTD2018)
Figure 3: AnaptysBio Inc capital raising volume and value trend (2014-YTD2018)
Figure 4: AnaptysBio Inc capital raising by deal type (2014-YTD2018)

★海外企業調査レポート[AnaptysBio Inc:企業のM&A・事業提携・投資動向]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • California Pizza Kitchen, Inc.
    California Pizza Kitchen, Inc. - Strategy, SWOT and Corporate Finance Report Summary California Pizza Kitchen, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • DaVita Inc.:企業のM&A・事業提携・投資動向
    DaVita Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's DaVita Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, ca …
  • China National Petroleum Corp:石油・ガス:M&Aディール及び事業提携情報
    Summary China National Petroleum Corp (CNPC) is an integrated energy company. Its businesses cover oil and gas exploration and development, refining and chemicals, marketing and trading, pipeline transmission and stockpiling, technical services, engineering construction, equipment manufacturing, fin …
  • Cemex SAB de CV (CEMEXCPO):企業の財務・戦略的SWOT分析
    Cemex SAB de CV (CEMEXCPO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Hydro-Electric Corporation-エネルギー分野:企業M&A・提携分析
    Summary Hydro-Electric Corporation (Hydro Tasmania) is a state-owned clean energy company that generates, trades and sells power; sells natural gas; and provides consulting services. It generates electricity using various energy sources such as water, wind and natural gas. The company sells the elec …
  • Washington University in St Louis:医療機器:M&Aディール及び事業提携情報
    Summary Washington University in St Louis (WUSTL), a subsidiary of University of Washington is an educational university which provides education and research services. The university provides various courses of bachelor’s, master’s, and doctoral degrees in a wide range of traditional and interdisci …
  • Formula Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析
    Summary Formula Pharmaceuticals Inc (Formula Pharmaceuticals) is an oncology company that develops chimeric antigen receptor (CAR) immunotherapy for oncology and autoimmune diseases. The company’s pipeline products include CIK-CAR.CD19, used as B-lymphocyte surface antigen; CIK-CAR.CD33, used for th …
  • P2 Energy Solutions Inc:石油・ガス:M&Aディール及び事業提携情報
    Summary P2 Energy Solutions Inc (P2 Energy), a subsidiary of P2ES Holdings Inc, is an oilfield services company that develops and offers oilfield software solutions. The company provides various tools for environmental, health and safety, finance and accounting, land management and geospatial data, …
  • Resona Holdings, Inc.:企業の戦略・SWOT・財務情報
    Resona Holdings, Inc. - Strategy, SWOT and Corporate Finance Report Summary Resona Holdings, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Dalet S.A. (DLT):企業の財務・戦略的SWOT分析
    Dalet S.A. (DLT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • BioMarin Pharmaceutical Inc (BMRN):企業の財務・戦略的SWOT分析
    BioMarin Pharmaceutical Inc (BMRN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Zalando SE:企業の戦略・SWOT・財務分析
    Zalando SE - Strategy, SWOT and Corporate Finance Report Summary Zalando SE - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Mahle GmbH:企業の戦略的SWOT分析
    Mahle GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • Black Box Corp (BBOX):企業の財務・戦略的SWOT分析
    Black Box Corp (BBOX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Lattice Semiconductor Corp (LSCC):企業の財務・戦略的SWOT分析
    Lattice Semiconductor Corp (LSCC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Atmos Energy Corp:企業の財務・戦略的SWOT分析
    Atmos Energy Corp - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • InCarda Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary InCarda Therapeutics Inc (InCarda) is a biopharmaceutical company that concentrates on the development of transformative therapies for cardiovascular conditions through the inhalation route. The company’s lead product candidate includes InRhythm, an inhaled antiarrhythmic for acute treatment …
  • RXi Pharmaceuticals Corp (RXII):製薬・医療:M&Aディール及び事業提携情報
    Summary RXi Pharmaceuticals Corp (RXi) is a biotechnology company that discovers, develops and commercializes immuno-oncology therapeutics to treat cancer. The company’s technology sd-rxRNA includes RXI-109 and IncRNA. Its lead product candidate is RXI-109, an sd-rxRNA that reduces the expression of …
  • Cogentix Medical Inc (CGNT):企業の財務・戦略的SWOT分析
    Summary Cogentix Medical Inc (Cogentix Medical), formerly Vision-Sciences Inc, is a medical device company that designs, develops, manufactures and markets fiberoptic and video endoscopy products. The company’s major products include PrimeSight endoscopy systems, Urgent PC neuromodulation system and …
  • Tap Oil Ltd (TAP):石油・ガス:M&Aディール及び事業提携情報
    Summary Tap Oil Ltd (Tap Oil) is an oil and gas company that offers exploration, development and production of oil and natural gas interests. The company holds interests in Manora oil field in the Gulf of Thailand and holds a number of exploration and production permits in Australia’s Carnarvon Basi …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆